News

Published on 28 Feb 2024 on Zacks via Yahoo Finance

Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates


Article preview image

Inhibrx, Inc. (INBX) came out with a quarterly loss of $1.73 per share versus the Zacks Consensus Estimate of a loss of $1.07. This compares to loss of $0.95 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -61.68%. A quarter ago, it was expected that this company would post a loss of $1.01 per share when it actually produced a loss of $1.10, delivering a surprise of -8.91%.

Over the last four quarters, the company has not been able to surpass consensus EPS estimates.

NASDAQ.INBX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates

Inhibrx, Inc. (INBX) came out with a quarterly loss of $1.73 per share versus the Zacks Consensus...

Zacks via Yahoo Finance 28 Feb 2024

Inhibrx (INBX) Up 6% on Sale of Rare Disease Drug to Sanofi

Inhibrx INBX and Sanofi SNY announced a definitive agreement wherein the latter will acquire the ...

Zacks via Yahoo Finance 21 Jan 2024

Inhibrx, Inc. (INBX) Soars 8.9%: Is Further Upside Left in the Stock?

Inhibrx, Inc. INBX shares ended the last trading session 8.9% higher at $36.30. The jump came on ...

Zacks via Yahoo Finance 21 Jan 2024

12 Best High Risk High Reward Stocks To Buy Now

In this piece, we will take a look at the 12 best high risk high reward stocks to buy now. If you...

Insider Monkey via Yahoo Finance 1 Sep 2023

Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session By...

Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Investing.com 29 Aug 2023

Inhibrx, Inc. (INBX) Reports Q1 Loss, Lags Revenue Estimates

Inhibrx, Inc. (INBX) came out with a quarterly loss of $1.12 per share versus the Zacks Consensus...

Zacks via Yahoo Finance 8 May 2023

Strength Seen in Inhibrx, Inc. (INBX): Can Its 9.9% Jump Turn into More Strength?

Inhibrx, Inc. INBX shares soared 9.9% in the last trading session to close at $26.99. The move wa...

Zacks via Yahoo Finance 4 May 2023

The past year for Inhibrx (NASDAQ:INBX) investors has not been profitable

These days it's easy to simply buy an index fund, and your returns should (roughly) match the mar...

Simply Wall St. via Yahoo Finance 23 Mar 2023

Inhibrx, Inc. (INBX) Reports Q4 Loss, Misses Revenue Estimates

Inhibrx, Inc. (INBX) came out with a quarterly loss of $0.95 per share versus the Zacks Consensus...

Zacks via Yahoo Finance 6 Mar 2023

Should You Hold Inhibrx (INBX)?

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quart...

Insider Monkey via Yahoo Finance 15 Jan 2023